![Restoration of Li+ pathways in the [010] direction during direct regeneration for spent LiFePO4](http://pubs.rsc.org/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5EE00641D)
.jpg)
Lilly, J&J, Pfizer and Sanofi back Teva fight against IRA drug negotiation program
In a proposed amicus brief, Eli Lilly, Johnson & Johnson, Pfizer and Sanofi have backed a Teva lawsuit against the Centers for Medicare & Medicaid Services (CMS) for how it is implementing the Inflation Reduction Act's drug price negotiation program.
In a proposed amicus brief, Eli Lilly, Johnson & Johnson, Pfizer and Sanofi have backed a Teva lawsuit against the Centers for Medicare & Medicaid Services (CMS) for how it is implementing the Inflation Reduction Act's drug price negotiation program.
